What we are looking for
- New licensing or acquisition opportunities for our territories or in some instances globally to strengthen our corporate portfolio (Rx and Orphan, OTC). Opportunities should fall into the following areas:
- Metabolic diseases
- Orphan and rare diseases
- Partners for our R&D projects
- To co-operate with commercially well-established local partners in the countries where we do not have or plan to have a direct presence
Recordati is also proactively seeking products to complete local or regional portfolios.